BEAM · Beam Therapeutics Inc.
$26.75
+0.24 (+0.91%)
At close · Aug 14
Market Cap
$2.76B
Shares
103.29M
Beam Therapeutics Inc. Earnings Call Transcripts
Every quarterly earnings call for Beam Therapeutics Inc. (BEAM) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Earnings call
FY25 · Q4
2026-02-24
Beam Therapeutics Inc. Q4 FY2025 Earnings Call
Confident tone
New PKU program (BEAM-304)
Sickle cell disease program
Platform and predictability
Revenue
$114.11M*
▲ 279.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-05
Beam Therapeutics Inc. Q3 FY2024 Earnings Call
Confident tone
BEAM-101 / BEACON Phase 1/2 in sickle cell disease
ESCAPE antibody-based conditioning platform
BEAM-302 in alpha-1 antitrypsin deficiency (AATD)
Revenue
$14.27M
▼ 17% YoY Diluted EPS
$-1.17
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-01-10
Beam Therapeutics Inc. Q4 FY2021 Earnings Call
Revenue
$51.07M*
▲ 851050% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-10
Beam Therapeutics Inc. Q3 FY2020 Earnings Call
Revenue
$6,000
▲ 0% YoY Diluted EPS
$-0.69
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Showing 1–4 of 4 earnings calls
Key facts
CIK
1745999
CUSIP
07373V105
13F (30d)
269 filings
261 filers
Visit website
Investor relations